DrugDashboards

Market view

quinapril and hydrochlorothiazide 20/12.5 · Tablet

1 marketed package NDCs · 1 active manufacturer

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for quinapril and hydrochlorothiazide 20/12.5, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Angiotensin Converting Enzyme Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Quinapril and hydrochlorothiazide 20/12.5 in shortage right now?
No. FDA does not currently list Quinapril and hydrochlorothiazide 20/12.5 in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Quinapril and hydrochlorothiazide 20/12.5?
1 company has marketed Quinapril and hydrochlorothiazide 20/12.5 in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.